早期强化降压联合亚低温治疗对脑出血患者术后再出血和预后的影响

来源 :中国药物经济学 | 被引量 : 0次 | 上传用户:xiaofagn
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨早期强化降压联合亚低温治疗对脑出血患者术后再出血和预后的影响。方法选取2013年4月至2014年4月我院收治的脑出血患者95例,随机分为研究组48例,对照组47例。对照组患者行标准降压治疗,研究组患者行早期强化降压联合亚低温治疗,分析两组患者术后再出血和预后情况。结果研究组患者术后再出血率为4.2%,明显低于对照组的29.8%;研究组患者预后优良率为85.4%,明显高于对照组的70.2%,差异均有统计学意义(均P<0.05)。结论早期强化降压联合亚低温治疗可明显降低脑出血患者术后再出血率,并改善患者预后。“,”Objective To explore the effect of early intensive antihypertensive combined with mild hypothermia treatment of rebleeding in patients with cerebral hemorrhage after operation and the prognosis of the patients. Methods In 95 patients from 2013 April to 2014 April in our hospital were randomly divided into cerebral hemorrhage,48 cases of the study group,47 cases in the control group.The control group underwent standard guide for antihypertensive therapy,study group underwent early intensive blood pressure lowering combined with mild hypothermia treatment,and prognosis analysis of two groups of postoperative rebleeding.Results Research group of patients with postoperative rebleeding rate was 4.2%,significantly lower than the control group of 29.8% patients;prognosis group of excellent and good rate was 85.4%,significantly higher than 70.2% in the control group,the difference was statisticaly significant(P<0.05).Conclusion Intensive blood pressure lowering combined with mild hypothermia can significantly reduce the rate of early rebleeding in patients with cerebral hemorrhage after operation,and improve the prognosis of the patients.
其他文献
期刊
据联合国新闻网11月4日消息,联合国欧洲经济委员会当天发表媒体通报称,该机构下设的农业质量标准工作组在当天举行的第71届会议上,通过了有关柿子的第一个国际质量标准,并将
2008年中国沪市A股经历了全球最严重的跌幅,“大小非”减持是主要原因之一.文章通过博弈模型对该问题进行了分析.对于“大小非”的违规减持,短期可以通过加大惩罚力度解决;从
期刊
期刊
期刊
期刊
期刊
本文通过对荣华二采区10
期刊
期刊